Next Article in Journal / Special Issue
Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics
Previous Article in Journal
Reevaluation of the Acute Cystitis Symptom Score, a Self-Reporting Questionnaire. Part II. Patient-Reported Outcome Assessment
Previous Article in Special Issue
Streptomyces Differentiation in Liquid Cultures as a Trigger of Secondary Metabolism
Open AccessReview

Concepts and Methods to Access Novel Antibiotics from Actinomycetes

1
Department Microbial Natural Products, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany
2
German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany
*
Author to whom correspondence should be addressed.
Received: 12 April 2018 / Revised: 14 May 2018 / Accepted: 17 May 2018 / Published: 22 May 2018
(This article belongs to the Special Issue Actinomycetes: The Antibiotics Producers)
Actinomycetes have been proven to be an excellent source of secondary metabolites for more than half a century. Exhibiting various bioactivities, they provide valuable approved drugs in clinical use. Most microorganisms are still untapped in terms of their capacity to produce secondary metabolites, since only a small fraction can be cultured in the laboratory. Thus, improving cultivation techniques to extend the range of secondary metabolite producers accessible under laboratory conditions is an important first step in prospecting underexplored sources for the isolation of novel antibiotics. Currently uncultured actinobacteria can be made available by bioprospecting extreme or simply habitats other than soil. Furthermore, bioinformatic analysis of genomes reveals most producers to harbour many more biosynthetic gene clusters than compounds identified from any single strain, which translates into a silent biosynthetic potential of the microbial world for the production of yet unknown natural products. This review covers discovery strategies and innovative methods recently employed to access the untapped reservoir of natural products. The focus is the order of actinomycetes although most approaches are similarly applicable to other microbes. Advanced cultivation methods, genomics- and metagenomics-based approaches, as well as modern metabolomics-inspired methods are highlighted to emphasise the interplay of different disciplines to improve access to novel natural products. View Full-Text
Keywords: metagenomics; rare actinomycetes; dereplication; metabolomics; genome mining; natural products metagenomics; rare actinomycetes; dereplication; metabolomics; genome mining; natural products
Show Figures

Figure 1

MDPI and ACS Style

Hug, J.J.; Bader, C.D.; Remškar, M.; Cirnski, K.; Müller, R. Concepts and Methods to Access Novel Antibiotics from Actinomycetes. Antibiotics 2018, 7, 44. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics7020044

AMA Style

Hug JJ, Bader CD, Remškar M, Cirnski K, Müller R. Concepts and Methods to Access Novel Antibiotics from Actinomycetes. Antibiotics. 2018; 7(2):44. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics7020044

Chicago/Turabian Style

Hug, Joachim J.; Bader, Chantal D.; Remškar, Maja; Cirnski, Katarina; Müller, Rolf. 2018. "Concepts and Methods to Access Novel Antibiotics from Actinomycetes" Antibiotics 7, no. 2: 44. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics7020044

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop